Crossmark

Tumor-driven purinergic signalling promotes RBFOX1 loss and chemotherapy-induced cardiotoxicity

Published Online: 2026-02-08

Published Print: 2026-02

Authors

Shatat, Abdel-Aziz S.
License Information

Text and Data Mining valid from 2026-02-01

Version of Record valid from 2026-02-01
More Information

Article History

Received: 7 January 2026

Accepted: 9 January 2026

First Online: 8 February 2026

Declarations

:

: The authors declare no competing interests.

Document is current